Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema

Details

Instance of

clinical trial

Start time

March 2014

End time

December 2016

Main subject

hypoxia, pulmonary emphysema

clinical trial phase

phase I clinical trial, phase II clinical trial

maximum age

75

minimum age

35

number of participants

0

study type

interventional study

title

Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema